Source: Annual Congress 2010 - Experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Hameed, S. Francis, C. Newman, D. Crossman, A. Lawrie (Sheffield, United Kingdom). Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 1075

Member's Comments

No comment yet.

Related content which might interest you: Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease. Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Fibrinogen plasma levels and disease severity in pulmonary artery hypertension Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 The association between pulmonary arterial hypertension secondary to chronic lung disease and serum asymmetric dimethylarginine levels Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 How to detect disease progression in pulmonary arterial hypertension Source: Eur Respir Rev 2012; 21: 40-47 Year: 2012 P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 L-arginine plasma levels correlate with severity of primary pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 560s Year: 2004 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Increased TNFα production in whole blood is associated with disease severity in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 497s Year: 2002 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis Source: Eur Respir J 2014; 43: 1530-1532 Year: 2014